O’Sullivan, David Max Planck Institute of Immunobiology and Epigenetics, Max Planck Society;
Pearce, Erika Max Planck Institute of Immunobiology and Epigenetics, Max Planck Society;
Mathew, N. R., Baumgartner, F., Braun, L., O’Sullivan, D., Thomas, S., Waterhouse, M., et al. (2018). Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT-3-ITD-mutant leukemia cells. Nature Medicine, 24, 282-291. doi:10.1038/nm.4484.